Toshimitsu Fujii
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Data-driven subphenotyping uncovers ulcerative colitis subtype with high risk for relapse in Japan: a prospective multicenter cohort study.
Journal: The Lancet regional health. Western Pacific
Published: June 03, 2026
Efficacy and safety of upadacitinib for Crohn's disease in patients in East Asia: a post hoc analysis of randomized phase 3 studies.
Journal: Journal of gastroenterology
Published: April 07, 2026
Case Report of a Rapidly Progressive Indolent T-Cell Lymphoma of the Gastrointestinal Tract.
Journal: DEN open
Published: February 06, 2026
A case of immune-mediated adverse events enterocolitis and duodenitis with gastrointestinal bleeding successfully treated with ustekinumab.
Journal: Clinical journal of gastroenterology
Published: January 29, 2026
Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulators or advanced therapies: post hoc analysis of the phase 2/3 J-True North study.
Journal: Intestinal research
Published: January 23, 2026
Leucine-Rich Alpha-2 Glycoprotein Is an Accurate Serum Marker for Endoscopic and Histological Remission in Ulcerative Colitis.
Journal: Inflammatory intestinal diseases
Published: November 11, 2025
Auditory Involvement in Inflammatory Bowel Disease: Clinical Predictors and Prognostic Implications.
Auditory Involvement in Inflammatory Bowel Disease: Clinical Predictors and Prognostic Implications.
Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Published: November 03, 2025
Stricture dynamics and prognosis during biologic therapy in ileal Crohn's disease: a real-world cohort.
Journal: Inflammatory bowel diseases
Published: October 17, 2025
Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 08, 2025
Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis.
Journal: Digestion
Published: October 02, 2025
Efficacy and Rapid Response of Ustekinumab for Hospitalized Patients With Severe Ulcerative Colitis.
Efficacy and Rapid Response of Ustekinumab for Hospitalized Patients With Severe Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: August 13, 2025
Last Updated: 09/26/2026